HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoning Wang Selected Research

Multiple Myeloma

4/2024Exploring natural killer cell-related biomarkers in multiple myeloma: a novel nature killer cell-related model predicting prognosis and immunotherapy response using single-cell study.
9/2023Pharmacokinetics and Metabolism of Melflufen, an Alkylating Peptide-Drug Conjugate, in Patients with Relapsed Refractory Multiple Myeloma.
12/2022Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma.
12/2021Efficacy and cost of G-CSF derivatives for prophylaxis of febrile neutropenia in lymphoma and multiple myeloma patients underwent autologous hematopoietic stem cell transplantation.
1/2021A Novel Model of Tumor-Infiltrating B Lymphocyte Specific RNA-Binding Protein-Related Genes With Potential Prognostic Value and Therapeutic Targets in Multiple Myeloma.
3/2020Identification of glutathione S-transferase π 1 as a prognostic proteomic biomarker for multiple myeloma using proteomic profiling.
1/2020Effective mobilization with etoposide and cyclophosphamide for collection of peripheral blood stem cell in patients with multiple myeloma.
10/2017Therapeutic experience of vincristine/cyclophosphamide/melphalan or mitoxantrone/prednisone combination therapy plus thalidomide as first-line induction therapy for newly diagnosed multiple myeloma in a single institution of China.
12/2014Arsenic Trioxide Combined with VCMP or VAD Chemotherapy in Patients with Refractory or Relapsed Multiple Myeloma in a Single Institution of China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoning Wang Research Topics

Disease

50Neoplasms (Cancer)
02/2024 - 06/2006
13Infections
02/2023 - 07/2004
11Necrosis
05/2022 - 05/2008
9Multiple Myeloma
04/2024 - 12/2014
9Fibrosis (Cirrhosis)
04/2021 - 09/2011
8Inflammation (Inflammations)
01/2023 - 01/2006
7Liver Diseases (Liver Disease)
05/2024 - 01/2016
7Lung Neoplasms (Lung Cancer)
10/2022 - 01/2016
6Squamous Cell Carcinoma of Head and Neck
01/2024 - 08/2019
6Liver Cirrhosis (Hepatic Cirrhosis)
08/2023 - 01/2015
6Hypoxia (Hypoxemia)
01/2022 - 08/2014
5Breast Neoplasms (Breast Cancer)
02/2024 - 11/2015
5Non-alcoholic Fatty Liver Disease
08/2023 - 10/2016
5Graft vs Host Disease (Graft-Versus-Host Disease)
02/2023 - 05/2020
5Pain (Aches)
01/2023 - 01/2007
5COVID-19
09/2021 - 01/2020
5Hepatocellular Carcinoma (Hepatoma)
11/2019 - 01/2011
4Carcinoma (Carcinomatosis)
01/2023 - 01/2013
4Cognitive Dysfunction
01/2023 - 01/2015
4Leukemia
01/2021 - 05/2012
4Myocardial Infarction
01/2018 - 07/2014
3Papillary Thyroid Cancer
12/2023 - 01/2017
3Cholestasis
08/2023 - 01/2017
3Poisoning
08/2023 - 11/2021
3Febrile Neutropenia
07/2023 - 02/2019
3Hearing Loss (Hearing Impairment)
05/2023 - 01/2013
3Body Weight (Weight, Body)
01/2023 - 02/2016
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2022 - 01/2015
3Lung Injury
01/2022 - 01/2006
3Neoplasm Metastasis (Metastasis)
01/2022 - 01/2018
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 01/2018
3Alzheimer Disease (Alzheimer's Disease)
01/2022 - 09/2012
3Postmenopausal Osteoporosis
01/2022 - 01/2022
3Acute Promyelocytic Leukemia
12/2020 - 05/2012
3Melanoma (Melanoma, Malignant)
11/2019 - 06/2006
3Stomach Neoplasms (Stomach Cancer)
11/2018 - 06/2012
3Carcinogenesis
01/2017 - 03/2014
3Colorectal Neoplasms (Colorectal Cancer)
11/2015 - 05/2012
2Hyperglycemia
04/2024 - 02/2016
2Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2024 - 12/2023
2Fever (Fevers)
01/2024 - 01/2023
2Chronic Hepatitis B
01/2024 - 01/2019
2Hypersensitivity (Allergy)
01/2024 - 09/2012
2Pneumonia (Pneumonitis)
02/2023 - 01/2023
2Giant Cell Tumor of Tendon Sheath
01/2023 - 11/2021
2Insulin Resistance
01/2023 - 07/2018
2Asthma (Bronchial Asthma)
01/2023 - 05/2008
2Type 2 Diabetes Mellitus (MODY)
01/2023 - 01/2018
2Anemia
12/2022 - 03/2020
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2022 - 01/2015

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
01/2024 - 05/2008
9Bile Acids and Salts (Bile Acids)IBA
08/2023 - 01/2015
8Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2015
7RNA (Ribonucleic Acid)IBA
12/2023 - 08/2019
6CytokinesIBA
01/2024 - 01/2007
6LipidsIBA
01/2023 - 04/2012
6hypericinIBA
01/2016 - 09/2011
5Therapeutic UsesIBA
12/2021 - 09/2007
5Streptozocin (Streptozotocin)FDA Link
11/2018 - 07/2015
4Interleukin-6 (Interleukin 6)IBA
05/2022 - 01/2017
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 05/2017
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2006
4VaccinesIBA
09/2021 - 06/2006
4Glycoproteins (Glycoprotein)IBA
01/2021 - 01/2019
4MicroRNAs (MicroRNA)IBA
01/2020 - 01/2011
3Melphalan (Alkeran)FDA LinkGeneric
09/2023 - 12/2014
3Fatty Acids (Saturated Fatty Acids)IBA
08/2023 - 01/2018
3SteroidsIBA
01/2023 - 05/2020
3LipopolysaccharidesIBA
05/2022 - 04/2016
3Glucose (Dextrose)FDA LinkGeneric
05/2022 - 01/2018
3Polysaccharides (Glycans)IBA
01/2022 - 10/2018
3Estrogens (Estrogen)FDA Link
01/2022 - 12/2017
3Long Noncoding RNAIBA
01/2022 - 08/2019
3Messenger RNA (mRNA)IBA
03/2021 - 01/2006
3FlavonoidsIBA
01/2021 - 01/2013
3Matrix Metalloproteinases (MMPs)IBA
01/2019 - 09/2011
3Indicators and Reagents (Reagents)IBA
01/2018 - 02/2013
3AntioxidantsIBA
01/2016 - 01/2015
3fosbretabulin (combretastatin A4)IBA
11/2015 - 09/2011
3Liposomes (Liposome)IBA
09/2012 - 01/2012
2Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2024 - 02/2023
2LigandsIBA
12/2023 - 01/2013
2Glutathione (Reduced Glutathione)IBA
05/2023 - 01/2016
2EnzymesIBA
02/2023 - 01/2022
2Palmitic Acid (Hexadecanoic Acid)IBA
01/2023 - 01/2018
2CateninsIBA
01/2023 - 07/2015
2Cadherins (E-Cadherin)IBA
01/2023 - 07/2015
2pexidartinibIBA
01/2023 - 11/2021
2OsteopontinIBA
01/2022 - 01/2018
2Formaldehyde (Formol)FDA Link
01/2022 - 10/2018
2Transcription Factors (Transcription Factor)IBA
01/2022 - 11/2019
2ParaffinIBA
01/2022 - 10/2018
2NF-kappa B (NF-kB)IBA
01/2022 - 01/2018
2ChemokinesIBA
01/2022 - 01/2018

Therapy/Procedure

26Therapeutics
02/2024 - 07/2007
5Immunotherapy
04/2024 - 05/2016
4Hematopoietic Stem Cell Transplantation
02/2023 - 01/2020
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
07/2023 - 05/2020
2Splenectomy
12/2022 - 12/2011
2Catheter Ablation
01/2022 - 01/2017